Cargando…
Astragaloside IV Suppresses High Glucose-Induced NLRP3 Inflammasome Activation by Inhibiting TLR4/NF-κB and CaSR
Long-term exposure to high glucose induces vascular endothelial inflammation that can result in cardiovascular disease. Astragaloside IV (As-IV) is widely used for anti-inflammatory treatment of cardiovascular diseases. However, its mechanism of action is still not fully understood. In this study, w...
Autores principales: | Leng, Bin, Zhang, Yingjie, Liu, Xinran, Zhang, Zhen, Liu, Yang, Wang, Hongxin, Lu, Meili |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6398021/ https://www.ncbi.nlm.nih.gov/pubmed/30906223 http://dx.doi.org/10.1155/2019/1082497 |
Ejemplares similares
-
OR11-003 - The NLRP3 inflammasome is regulated by CaSR
por: Chae, JJ, et al.
Publicado: (2013) -
Tojapride prevents CaSR‐mediated NLRP3 inflammasome activation in oesophageal epithelium irritated by acidic bile salts
por: Yin, Xiao‐Lan, et al.
Publicado: (2019) -
Astragaloside IV attenuates inflammatory response mediated by NLRP‐3/calpain‐1 is involved in the development of pulmonary hypertension
por: Sun, Yang, et al.
Publicado: (2020) -
Physiological studies in heterozygous calcium sensing receptor (CaSR) gene-ablated mice confirm that the CaSR regulates calcitonin release in vivo
por: Fudge, Neva J, et al.
Publicado: (2004) -
Calcium Sensing Receptor-Related Pathway Contributes to Cardiac Injury and the Mechanism of Astragaloside IV on Cardioprotection
por: Lu, Meili, et al.
Publicado: (2018)